上集講述了PD1/PDL1在醫治癌細胞免疫治療方面的重要性,接下來我們將會繼續深入探討問題。1417Please respect copyright.PENANAHkPW66JVHO
1417Please respect copyright.PENANAUOSDhTZcnE
上集:https://www.penana.com/article/4711251417Please respect copyright.PENANAoKDvPqcRyO
1417Please respect copyright.PENANAsYnylcci6u1417Please respect copyright.PENANAH65Odojiju
1417Please respect copyright.PENANA9JwxVhou45
(圖1)雖然阻擋PD1/PDL1可以增強T cell辨認癌細胞的能力,但另一個重要的問題是,如何確保有足夠的T cell殺滅癌細胞呢?1417Please respect copyright.PENANARdrdyhNvPp
1417Please respect copyright.PENANAOHXQdW3231
就算成功糾正免疫系統細胞懂得把癌細胞辨認為外來之物,但免疫系統細胞數量不足的話,依然是不會達到重大效果的。1417Please respect copyright.PENANAMZO3whVtZ2
1417Please respect copyright.PENANAV1hSkZJbeO
換句話說,我們需要一道能夠提升針對癌細胞的T cell數量手段。1417Please respect copyright.PENANAYlNSSxhAq5
1417Please respect copyright.PENANAmsKD5Qx8VR1417Please respect copyright.PENANAe5jUZXB14E
1417Please respect copyright.PENANAd2bUsUtNZL
(圖2)T cell的產生數量,接近可以說是由Antigen Presenting Cells(APC)來決定;1417Please respect copyright.PENANAgsITiDyDfu
APC可以睇成為一堆負責把癌細胞獨特Neoantigen帶來T cell面前的細胞。1417Please respect copyright.PENANAShZ7YYZMaI
1417Please respect copyright.PENANADGzkaLR3Ss
忘記甚麼是Neoantigen的話,可重溫上一集。1417Please respect copyright.PENANAPOTzw1lurk
1417Please respect copyright.PENANA6ZI4KhPm2t
當APC展示癌細胞的Neoantigen予T cell的receptor後,另一個必需的動作就是T cell表面的CD28與APC表面的B7合併。1417Please respect copyright.PENANAL6UInniGuE
1417Please respect copyright.PENANAK2AiyMKaNS
只要兩者條件達成的話,負責對付對應癌細胞的T cell數量及效力便會大增。1417Please respect copyright.PENANALwwyiAehKi
1417Please respect copyright.PENANAYXurtgP0FU1417Please respect copyright.PENANAwAfGBNWlPo
1417Please respect copyright.PENANAR9P9o2z9of
(圖3)然而,當T cell數量產生至一定程度的時候,T cell便會產生出CTLA4。CTLA4會搶奪CD28的位置,與B7合併。1417Please respect copyright.PENANA66y2ixoO0r
1417Please respect copyright.PENANA9SB9y8HO2V
而當CTLA4與B7合併後,T cell所產生的數量及威力就會大減。1417Please respect copyright.PENANAzwtV4UXSg8
1417Please respect copyright.PENANA2JuLN0GHiD
這個CTLA4產生的機制是與生俱來的,目的就是為了避免產生過量的T cell,以免身體會產生不良反應。1417Please respect copyright.PENANAKQ1PpVXvK71417Please respect copyright.PENANAc4r4uPowjy
1417Please respect copyright.PENANAi33E786Frw
(圖4)只不過的是,現時癌細胞大敵當前,燃眉之急就是要調動大量的T cell前往討伐癌細胞。1417Please respect copyright.PENANAtGTHquMXfq
1417Please respect copyright.PENANAyHXpst7YQW
為此,我們重施應對PD1/PDL1故技,利用抗體阻擋CTLA4,確保CD28及B7持續合併,不斷產生效力高強的T cell。1417Please respect copyright.PENANAuxu7Ejs7b21417Please respect copyright.PENANAfuiOraNcSv
1417Please respect copyright.PENANAMODCbMbkrC
(圖5)簡略的總結來說,為了確保有足夠的T cell消滅癌細胞,我們不惜採用阻擋CTLA4的抗體,號令身體持續產生效力高強的T cell。1417Please respect copyright.PENANAf2OCfvYIZL
而另一邊廂,我們亦同時利用阻擋PD1/PDL1的抗體,確保T cell能夠順利把癌細胞辨認成為外來物,將其制裁。1417Please respect copyright.PENANAKVsN2TUUmO
1417Please respect copyright.PENANAMEN6RDi99R
這CTLA4抗體及PD1/PDL1抗體的雙管齊下療法,將能大大提升免疫治療的效率。1417Please respect copyright.PENANA0NuN7Mvsi3
1417Please respect copyright.PENANAlNUmjcMs9E
但是,並不是所有病人也能依靠這方法而得益,原因是T cell沒法能夠順利抵達癌細胞的位置以及滲入癌細胞的內部作有效的消滅。1417Please respect copyright.PENANAh5OFFQ6LZK
1417Please respect copyright.PENANAhYfQUwD32j
這一方面,我們將會在下一篇免疫治療的最終章再作探討。1417Please respect copyright.PENANA6YTOQfiPeX
1417Please respect copyright.PENANA0lzsixKh5w
1417Please respect copyright.PENANAwI3ocip1hf
如果想我快啲出文的話,請入去Penana網站科普專欄–薯不揀單俾一個like以及Bookmark,這對我非常之重要。1417Please respect copyright.PENANAdN0TJWUqt8
1417Please respect copyright.PENANAGsTkjHAEfc
Link: https://www.penana.com/story/66244/%E7%A7%91%E6%99%AE%E5%B0%88%E6%AC%84-%E8%96%AF%E4%B8%8D%E6%8F%80%E5%96%AE/toc1417Please respect copyright.PENANAvgZAaiivNt
1417Please respect copyright.PENANAnXS8sycMQ6
同時亦可以在Penana網站裡按「買一嚿/半嚿薯仔」,以課金的方式推動我繼續搜羅資料寫文,多謝。1417Please respect copyright.PENANAAoa4FHcx9c
1417Please respect copyright.PENANAqPIFTQs12t
Link:1417Please respect copyright.PENANAkdY4Vphj8v
https://www.penana.com/user/27349/%E8%96%AF%E4%BB%94%E8%81%9E%E8%8C%B1%E8%8E%89/portfolio1417Please respect copyright.PENANAhmVn3Tc4Uz
1417Please respect copyright.PENANAYRBQzjcTfk
1417Please respect copyright.PENANApXHpLTv8qT
有興趣接收科普資訊的話,歡迎follow IG: potatopigtongue。1417Please respect copyright.PENANAIlMyRCUaOf
arrow_back
科普專欄–薯不揀單
more_vert
-
info_outline 資料
-
toc 目錄
-
share 分享
-
format_color_text 介面設置
-
exposure_plus_1 推薦
-
打賞
-
report_problem 檢舉
-
account_circle 登入
X
科普專欄–薯不揀單
作者:
薯仔聞茱莉

篇 #31
深入淺出–以免疫治療(Immunotherapy)手段醫治癌細胞(二)
喜歡 2
閱讀 1413
書籤 150
campaign
催更 0
打賞

按此加載下一章
X
每次催更後,作者都會收到通知!
smartphone100 → 催更
×
寫下你喜歡這個故事的地方
×
對此喜歡的人